Sort
64,565 grants matching “drug discovery”
Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs
$773,850Makedonka Mitreva · Washington University · R01 · FY2023 · AI
SBIR Phase II: Software Platform for Quality-by-Design Implementation
$773,753Paul Vaneikeren · Blue Reference · · FY2008 · TIP
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$773,738Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2018 · AI
Managing Atherosclerosis by Modulating HDL Function
$773,645M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2023 · HL
Managing Atherosclerosis by Modulating HDL Function
$773,645M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2025 · HL
Genetics and Mechanisms of Mitral Valve Prolapse
$773,633David J Milan · Massachusetts General Hospital · R01 · FY2015 · HL
Development of brain-penetrant, histone evicting anthracycline drugs for treatment of diffuse midline glioma
$773,607Michael A Koldobskiy · Johns Hopkins University · R61 · FY2025 · NS
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes
$773,574Michael Darin Cameron · Scripps Research Institute, The · U01 · FY2013 · AA
New Mexico Molecular Libraries Screening Center(RMI)
$773,540Larry A. Sklar · University Of New Mexico · U54 · FY2008 · MH
Columbia Injury Control Research Center
$773,524Guohua Li · Columbia University Health Sciences · R49 · FY2016 · CE
The Unviersity of Michigan Injury Center
$773,524Rebecca M. Cunningham · University Of Michigan At Ann Arbor · R49 · FY2016 · CE
BMC--BHASIN
$773,524Shalendar Bhasin · Boston Medical Center · P30 · FY2009 · AG
Signal Transduction Events and the Regulation of Cell Growth
$773,516Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2013 · CA
Mutation Enriched Targeted Re-Sequencing
$773,511Grant Wu · Transgenomic, Inc. · R42 · FY2016 · CA
DRUG DISCOVERY OF BAX ACTIVATORS FOR THE TREATMENT OF BREAST CANCER
$773,501University Of Texas Medical Branch At Galveston · · FY2017 · Department of the Army
Molecular Drivers of Vascular Stiffness and Metabolic Dysfunction in HIV-Induced Pulmonary Arterial Hypertension
$773,494Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway
$773,235Haifeng Eishingdrelo · Bioinvenu Corporation · R44 · FY2017 · MH
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses
$773,155Emelia J. Benjamin · Boston University Medical Campus · R01 · FY2017 · HL
New Quantitative Neuroimaging Metrics of Structural and Functional Connectivity of the Locus Coeruleus as a Novel Biomarker of Alzheimer's Disease Pathogenesis and Progression
$773,059Lawrence R. Frank · University Of California, San Diego · R01 · FY2018 · AG
Identification of metabolic alterations during cortical development in a human cellular model for 22q11.2 deletion syndrome
$772,968Anca Mirabela Pasca · Stanford University · R01 · FY2023 · MH
Genomic Database for Candida Albicans
$772,961Gavin J Sherlock · Stanford University · R01 · FY2011 · DE
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
$772,859Ambrose L. Cheung · Dartmouth College · R01 · FY2024 · AI
Pharmacological targeting of nascent modulators of opioid signaling
$772,800Kirill A. Martemyanov · University Of Florida · R01 · FY2024 · DA
Vanderbilt Genome Electronic Records Project
$772,709Dan M Roden · Vanderbilt University · U01 · FY2011 · HG
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
$772,673Issam A Awad · University Of Chicago · R01 · FY2020 · NS